期刊文献+

单组目标值试验样本量计算方法的比较研究 被引量:17

Comparison of sample size calculation methods for single arm OPC trials
原文传递
导出
摘要 目的探讨设计以率作为终点评价指标的单组目标值试验时,不同样本量计算方法间的区别。方法通过样本量计算原理与计算结果的比较,分析不同样本量计算方法间的差异,进一步通过Monte Carlo随机模拟方法,探讨使用不同方法所得样本量估计实际的检验把握度,验证所得结果的正确性。结果当预计事件发生率p和目标值p0相差10%时,近似正态法和一般精确概率法所得样本量和把握度较相近,但是当p接近1.0时(p>0.85),精确概率法所得样本量略低于近似正态法,且把握度明显低于近似正态法。小概率事件的精确概率法所需样本量始终低于近似正态法和一般精确概率法。随机模拟显示,在相同的参数设置下,近似正态法给出的样本量能够提供足够的研究把握度,而小概率事件的精确概率法所得样本量能提供的把握度过低。结论如果要检验某医疗器械的使用成功率是否不低于某个临床认可的标准,按照近似正态法计算的样本量,更能提供足够的检验把握度,尤其对于小规模的临床试验。 Objective To explore the differences of sample size calculation methods used for single arm OPC trials in which primary endpoint is proportion. Methods Sample size calculation principles and results were directly compared. Monte Carlo random simulation was used to validate the results. Results When expected event rate p and target value P0 has a 10% difference, sample size and power obtained from normal approximation method and binomial exact method were similar. However, when p was close to 1.0 ( P 〉 0. 85 ) , sample size and power obtained from binomial exact method were significantly lower than normal approximation method. Sample size obtained from rare event exact method was constantly smaller compared to normal approximation method and binomial exact method. Results from simulation showed that normal approximation method could offer sufficient power, but power obtained from rare event exact method was too low. Conclu- sions If the hypothesis of study was to demonstrate the success rate of certain medical device was larger than a clinical ap- proved target value, the normal approximation method provides strong statistical power, especially for small clinical trials.
机构地区 中国医学科学院
出处 《中华疾病控制杂志》 CAS 北大核心 2013年第11期993-996,共4页 Chinese Journal of Disease Control & Prevention
关键词 单组目标值试验 样本量 近似正态法 精确概率法 ingle aim OPC clinical trial Sample size Normal approximation method Binomial exact method
  • 相关文献

参考文献15

  • 1国家食品药品监督管理总局.影像型超声诊断设备(第三类)产品注册技术审查指导原则[EB/OL].(20104)7-01)[201302431].http://WWW.sda.gov.cn/WS01/CL0274/59891.html.
  • 2国家食品药品监督管理总局.医用x射线诊断设备(第三类)产品注册技术审查指导原则[EB/OL].(2010-07-01)[2013-01-30].http://www.sda.gov.cn/WS01/CL0274/59890.html.
  • 3国家食品药品监督管理总局.乳房植入体产品注册技术审查指导原则[EB/OL].(2011-03-24)[2013-01-28]http://www.sda.gov.cn/WSOl/CL0274/60443.html.
  • 4U.S. Food and Drug Administration. Clinical Study Designs for Catheter Ablation Devices for Treatment of Atria Flutter [ EB/OL1 . (2008-08-05) [ 2013-02-02 1. http ://www. fda. gov/MedicalDe- viees/DevieeRegulationandGuidance/GuidanceDoeuments/ucm070 919. htm.
  • 5U.S. Food and Drug Administration Center for Devices and Radio- logical Health. The Least Burdensome Provisions of the FDA Mod- ernization Act of 1997: Concept and Principles [ EB/OL 1- (2004-10-04) [2013-02-01 ]. http://www, fda. gov/MediealDe- vices/DeviceRegulationandGuidance/Guidan ceDocuments/uem085 994. htm.
  • 6U.S. Food and Dng Administration. Cardiac Ablalion Catheters Generic Arrhythmia Indications for Use [ EB/OL. (2002-07-01) [ 2013-02-22 ]. http://www, fda. gov/MedicalDevices/Device- RegulationandGuidance/GuidanceDocuments/ucm072860. htm.
  • 7吕德良,李雪迎,朱赛楠,姚晨.目标值法在医疗器械非随机对照临床试验中的应用[J].中国卫生统计,2009,26(3):258-260. 被引量:15
  • 8成琪,刘玉秀,陈林,刘丽霞.单组临床试验目标值法的精确样本含量估计及统计推断[J].中国临床药理学与治疗学,2011,16(5):517-522. 被引量:16
  • 9U.S. Food and Drug Administration. Summary of Safety and Ef- fectiveness Data ( SSED ) [ EB/OL ]. ( 2009201-29 ) [ 2013-02- 21]. http://www, fda. gov/downloads/AdvisoryCommittees/Com- mitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisory- Committee/CirculatorySystemDevicesPanel/UCM152225. pdf.
  • 10Dixon WJ, Massey FJ. Introduction to Statistical Analysis [ M]. 4th Ed. New York:McGraw-Hill Co, 1983.

二级参考文献39

共引文献38

同被引文献177

引证文献17

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部